1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Publication Number 20170360777

US 20170360777 A1
Patent NumberUS 09861630 B1
Application Number15674043
Filled DateAug 10, 2017
Priority DateJun 16, 2006
Publication DateDec 21, 2017
Original AssigneeH. Lundbeck As
Current AssigneeH. Lundbeck As
Inventor/ApplicantsAndre Faldt
Rene Holm
Heidi Lopez de Diego
André Faldt
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.